Outcomes of trimethoprim/ sulfamethoxazole treatment for ocular toxoplasmosis in Congolese patients

BACKGROUND: Ocular toxoplasmosis (OT) is the leading cause of infectious posterior uveitis in several areas worldwide. The combination of Trimethoprim/Sulfamethoxazole (TMP/SMX) has been presented as an attractive alternative to the “classic’ treatment therapy (Pyrimethamine/Sulfadiazine). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Nsiangani Lusambo, Nadine, Kaimbo Wa Kaimbo, Dieudonné, Ngoyi Mumba, Dieudonné Mumba, de-la-Torre, Alejandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617208/
https://www.ncbi.nlm.nih.gov/pubmed/37907920
http://dx.doi.org/10.1186/s12886-023-03183-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617208/
https://www.ncbi.nlm.nih.gov/pubmed/37907920
http://dx.doi.org/10.1186/s12886-023-03183-x

Ejemplares similares